Control of HSV-1 latency in human trigeminal ganglia--current overview.
about
Deciphering Human Cell-Autonomous Anti-HSV-1 Immunity in the Central Nervous SystemHerpes Simplex Virus Latency: The DNA Repair-Centered Pathway.Anti-Viral Properties of Amyloid-β Peptides.Update on herpes virus infections of the nervous system.Characterization of neuronal populations in the human trigeminal ganglion and their association with latent herpes simplex virus-1 infection.Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.Role of Proteolipid Protein in HSV-1 Entry in Oligodendrocytic Cells.Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3.SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication.Age-Dependent Differences in Pseudorabies Virus Neuropathogenesis and Associated Cytokine Expression.Blessing or curse? Proteomics in granzyme research.Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells.Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease.
P2860
Q26991623-896924FF-64ED-4301-B146-194639A98DCCQ30253050-8E671024-8682-4C23-AC46-6B0E94AC1A2EQ30390299-E51A3EEF-CD9F-4B30-8B07-111504EBFF9CQ34379006-21AE0367-CDE4-4B1A-A40E-4AC1BD566F32Q35075587-B8B6C9FA-3FCA-4A1F-8D37-CE94C29C644BQ35168425-F0AAB6DB-009D-41A5-83C5-F4AD32E2482DQ35903044-2E63F254-315D-4911-95B4-6F9A93ED170BQ36520832-D8AB6105-1E05-498F-854F-4E367181316FQ37010787-9D50F87A-6242-4C78-A603-5BD02B4F4C99Q37336418-48AFDE89-8EDB-49BC-ADC4-115F021666A8Q37560719-7639CDBB-AA55-44FF-A4E8-2CCBAAA1850DQ38200060-9359DFCC-3CFE-4EA2-B688-EB4EB2CCBC90Q38797410-4C73638D-437C-44C9-AC94-F0DF00D44850Q39239092-AA959BEE-8186-430B-B8D2-E3FB18A35514Q40216595-C647296D-9F9C-4B97-91D2-FECA468090CEQ45323787-993D78BB-D3CE-410D-A16A-44861B23FCB4Q51761118-91B5CDDA-786B-4BE7-A25C-89FD0806A78DQ55021072-3BA46B94-F5DB-405D-AA23-9C43AA0FCC49
P2860
Control of HSV-1 latency in human trigeminal ganglia--current overview.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@en
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@nl
type
label
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@en
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@nl
prefLabel
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@en
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@nl
P2860
P1476
Control of HSV-1 latency in human trigeminal ganglia--current overview.
@en
P2093
Kathrin Held
Tobias Derfuss
P2860
P2888
P304
P356
10.1007/S13365-011-0063-0
P577
2011-12-03T00:00:00Z